Nautilus Biotechnology (NAUT) Total Debt (2020 - 2021)
Nautilus Biotechnology's (NAUT) quarterly Total Debt came in at $30000.0 in Q1 2021, up 50.0% quarter-over-quarter from $20000.0 in Q3 2020.
Nautilus Biotechnology (NAUT) Total Debt (2020 - 2021) Analysis & Trends
Nautilus Biotechnology has disclosed Total Debt across 2 years of filings, most recently posting $30000.0 for Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Nautilus Biotechnology | 289.99 Mn | 194.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 30,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Jun 30, 2020 | 63,410.00 |